Metabolic
Survodutide
Clinical trials
4.10 reviewsPrimary purposes
Fat loss, Liver health
Relevant conditions
Obesity, Fatty liver
Mechanism of action
Dual glucagon and GLP-1 receptor agonist with strong effects on liver fat.
Details
Survodutide showed up to ~19% weight loss and improvement of MASH in phase 2 trials. Phase 3 trials are ongoing.
Verified sources & manufacturers
Coming soon – we are building a list of verified studies and manufacturers. Learn more
Community experiences
Sign in to write reviews and share experiences.
No reviews yet – be the first.